Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
New Long-Term treatment tested for debilitating skin itch condition
Disease control OngoingThis study is testing the long-term safety and effectiveness of nemolizumab, an injectable medication, for people with prurigo nodularis—a chronic skin condition causing intense itching and raised bumps. It follows 500 participants for up to 3.5 years to see if the treatment cont…
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Can a simple injection give you smoother, more radiant skin?
Symptom relief OngoingThis study is testing whether injections of a product called Restylane Skinboosters Vital can safely improve the quality of facial skin. About 171 Chinese adults with moderate to severe fine lines will receive either the injections or no treatment, and doctors will compare the re…
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC